285 N-acetylmuramoyl-L-alanine amidase-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 22 | 12.1 | 1.82× | q = 1.9e-4 | |
| Homogeneous non-metal compounds | 4 | 5.3 | 0.75× | q = 0.71 | |
| Nucleosides, nucleotides, and analogues | 0 | 6.8 | 0 | q = 1.3e-3 | |
| Organic acids and derivatives | 8 | 3.8 | 2.10× | not tested | |
| Organic oxygen compounds | 6 | 4.9 | 1.22× | not tested | |
| Benzenoids | 1 | 1.8 | 0.56× | not tested | |
| Lipids and lipid-like molecules | 1 | 2.7 | 0.36× | not tested | |
| Organoheterocyclic compounds | 1 | 3.8 | 0.26× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB09459 | TLA | L-tartaric acid | 63 |
| DB00141 | NAG | N-Acetylglucosamine | 19 |
| DB04736 | MLD | 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE | 10 |
| DB00160 | ALA | Alanine | 6 |
| DB03193 | STE | Stearic acid | 6 |
| DB14756 | SRT | meso-Tartaric acid | 6 |
| DB11091 | PEO | Hydrogen peroxide | 4 |
| DB02174 | DGN | D-Glutamine | 3 |
| DB02938 | SHV | Heptanoic acid | 3 |
| DB03017 | DAO | Lauric acid | 3 |
| DB03590 | API | 2,6-Diaminopimelic Acid | 3 |
| DB03796 | PLM | Palmitic Acid | 3 |
| DB08231 | MYR | Myristic acid | 3 |
| DB01694 | TAR | D-tartaric acid | 2 |
| DB02517 | DGL | D-Glutamic Acid | 2 |
| DB03066 | LAC | D-Lactic acid | 2 |
| DB03568 | BUA | Butyric Acid | 2 |
| DB03740 | NDG | N-acetyl-alpha-D-glucosamine | 2 |
| DB03940 | OXM | Oxamic Acid | 2 |
| DB00142 | GLU | Glutamic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| TLA | L(+)-TARTARIC ACID | 63 |
| ZNmetal | ZINC ION | 61 |
| NAmetal | SODIUM ION | 13 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 13 |
| LP5 | (R)-((2R,3S,4R,5R,6R)-3-HYDROXY-2-(HYDROXYMETHYL)-5-((R)-3-HYDROXYTETRADECANAMIDO)-6-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN-4-YL) 3-HYDROXYTETRADECANOATE | 9 |
| 6NA | HEXANOIC ACID | 8 |
| MLD | GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)-L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA | 8 |
| CL | CHLORIDE ION | 7 |
| ALA | ALANINE | 6 |
| SRT | S,R MESO-TARTARIC ACID | 6 |
| STE | STEARIC ACID | 6 |
| 11Z | 11-cyclohexylundecanoic acid | 4 |
| NImetal | NICKEL (II) ION | 4 |
| PEO | HYDROGEN PEROXIDE | 4 |
| PNR | 4-nitrophenyl hexadecanoate | 4 |
| RAM | alpha-L-rhamnopyranose | 4 |
| XXC | 7-phenylheptanoic acid | 4 |
| AMU | N-acetyl-beta-muramic acid | 3 |
| DGN | D-GLUTAMINE | 3 |
| ISJ | (3R,4R)-3-[(1-carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylic acid | 3 |